Hirakata, Japan

Fumio Mori

This inventor holds 4 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1995-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fumio Mori. Retrieved from https://idiyas.com/inventor/fumio-mori-zuk2f8xr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.7

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Osaka, JP (1996)
  • Hirakata, JP (1995 - 1998)

Company Filing History:


Years Active: 1995-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Fumio Mori: Innovator in Carboxylic Acid Compounds

Introduction

Fumio Mori is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of carboxylic acid compounds. With a total of 4 patents to his name, Mori's work has implications for the treatment of thrombotic diseases.

Latest Patents

Mori's latest patents include a carboxylic acid compound having a condensed ring and its pharmacologically acceptable salts. This novel compound demonstrates superior GPIIb/IIIa antagonism in mammals, including humans. It can be administered orally, has a long life in blood, low toxicity, and shows fewer side effects. These characteristics make it extremely useful for the prophylaxis and treatment of thrombotic diseases and other related conditions.

Career Highlights

Fumio Mori is associated with The Green Cross Corporation, where he continues to innovate in the pharmaceutical sector. His research focuses on compounds that can significantly improve patient outcomes in various medical conditions.

Collaborations

Mori has worked alongside notable colleagues such as Keigo Kosaka and Norifumi Nakamura, contributing to advancements in their shared field of expertise.

Conclusion

Fumio Mori's contributions to the development of carboxylic acid compounds highlight his role as a key innovator in the pharmaceutical industry. His work not only advances scientific knowledge but also has the potential to improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…